Regulation of thioredoxin mRNA in the rat uterus by gonadal steroids

Journal of Steroid Biochemistry and Molecular Biology

Volumn 68, Issue 5-6, 1999, Pages 203-209

  Sahlin, Lena ^a   Wang, Hong ^a   Masironi, Britt ^a   Holmgren, Arne ^b   Eriksson, Håkan ^a  

^a Department of Woman and Child Health   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRADIOL; FLUTAMIDE; FULVESTRANT; MESSENGER RNA; PROGESTERONE; SEX HORMONE; THIOREDOXIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HORMONAL REGULATION; NONHUMAN; OVARIECTOMY; RAT; RNA ANALYSIS; UTERUS;

ANDROGENS; ANIMALS; ESTROGEN ANTAGONISTS; FEMALE; GENE EXPRESSION REGULATION; HYPOPHYSECTOMY; OVARIECTOMY; PROESTRUS; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; THIOREDOXIN; UTERUS;

EID: 0033028961     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(99)00031-X     Document Type: Article

References (37)

1. P. Reichard, From RNA to DNA, why so many ribonucleotide reductases? Science 260 (1993) 1773-1777.
2. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54:1985;237-271.
3. Holmgren A., Björnstedt M. Thioredoxin and thioredoxin reductase. Meth. Enzymol. 252:1995;199-208.
4. Schenk H., Klein M., Erdbrugger W., Dröge W., Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Nat. Acad. Sci. 91:1994;1672-1676.
5. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
6. Schenk H., Vogt M., Dröge W., Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156:1996;765-771.
7. Hayashi S., Hajiro-Nakanishi K., Makino Y., Eguchi H., Yodoi J., Tanaka H. Functional modulation of estrogen receptor by redox state reference to thioredoxin as a mediator. Nucleic Acids Res. 25:1997;4035-4040.
8. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:1997;351-369.
9. Rubartelli A., Bajetto A., Allavena G., Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267:1992;24,161-24,164.
10. Ericson M.L., Hörling J., Wendel-Hansen, Holmgren A., Rosén A. Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res. 11:1992;201-207.
11. Rosén A., Lundman P., Carlsson M., Bhavani K., Holmgren A. A CD4+T cell line secreted factor, growth promoting for normal and leucemic cells, identified as thioredoxin. Int. Immunol. 7:1995;625-633.
12. Biguet C., Wakasugi N., Mishal Z., Holmgren A., Chouaib S., Tursz T., Wakasugi H. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J. Biol. Chem. 269:1994;28,865-28,870.
13. Powis G., Oblong J.E., Gasdaska P.Y., Berggren M., Hill S.R., Kirkpatrick D.L. The thioredoxin/ thioredoxin reductase system and control of cell growth. Oncology Res. 6:1994;539-544.
14. Sahlin L., Holmgren A., Eriksson H. Thioredoxin messenger ribonucleic acid is regulated by estradiol in the rat uterus. Biol. Reprod. 57:1997;1056-1059.
15. Sahlin L., Stjernholm Y., Holmgren A., Ekman G., Eriksson H. The expression of thioredoxin mRNA is increased in the human cervix during pregnancy. Mol. Human Reprod. 3:1997;1113-1117.
16. Iwai T., Fujii S., Nanbu Y., Nonogaki H., Konishi I., Mori T., Matsutani H., Yodoi J. Expression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, in the human ovary throughout the menstrual cycle. Virchows Archiv A Pathol. Anat. 420:1992;213-217.
17. Rozell B., Hansson H.A., Lutman M., Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur. J. Cell Biol. 38:1985;79-86.
18. Fujii S., Nanbu Y., Konishi I., Mori T., Masutani H., Yodoi J. Immunohistochemical localization of adult T-cell leukemia-derived factor, a human thioredoxin homologue, in human fetal tissues. Virchows Archiv A Pathol. Anat. 419:1991;317-326.
19. Maruyama T., Kitaoka Y., Sachi Y., Nakanoin K., Hirota K., Shiozawa T., Yoshimura Y., Fujii S., Yodoi J. Thioredoxin expression in the human endometrium during the menstrual cycle. Molec. Human Reprod. 3:1997;989-993.
20. Wakeling A.E., Dukes M., Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res. 51:1991;3867-3873.
21. Zarrow M.X., Yochim J.M., McCarthy J.L. The estrogens. Experimental Endocrinology. A sourcebook of basic techniques. 1964;37-38 Academic Press, New York.
22. Sahlin L., Norstedt G., Eriksson H. Estrogen regulation of the estrogen receptor and insulin-like growth factor-I in the rat uterus: A potential coupling between effects of estrogen and IGF-I. Steroids. 59:1994;421-430.
23. Durnam D.M., Palmiter R.D. A practical approach for quantitating specific mRNA by solution hybridization. Anal. Biochem. 131:1983;385-393.
24. Labarca C., Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:1980;344-352.
25. Lippoldt A., Padilla C.A., Gerst H., Andbjer B., Richter E., Holmgren A., Fuxe K. Localization of thioredoxin in the rat brain and functional implications. J. Neuroscience. 15:1995;6747-6756.
26. Tagaya Y., Maeda Y., Mitsui A., Kondo N., Matsui H., Hamuro J., Brown N., Arai K-I., Yokota T., Wakasugi H., Yodoi J. ATL-derived factor (ADF), an IL-2-receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J. 8:1989;757-764.
27. Ren X., Björnstedt M., Shen B., Ericson M.L., Holmgren A. Mutagenesis of structural half-cysteine residues in human thioredoxin and effects on the regulation of activity by selenodiglutathione. Biochemistry. 32:1993;9701-9708.
28. Melton D.A., Krieg P.A., Rebagliati M.R., Maniatis R., Zinn K., Green M.R. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing bacteriophage SP6 promoter. Nucl. Acids Res. 12:1984;7035-7056.
29. Sahlin L. Dexamethasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus. J. Steroid Biochem. Molec. Biol. 55:1995;9-15.
30. Scheffé H. The analysis of variance. 1959;John Wiley, New York.
31. Trembley G.B., Trembley A., Copeland N.G., Gilbert D.J., Jenkins N.A., Labrie F., Giguère V. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β Mol. Endocrinol. 11:1997;353-365.
32. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J-Å. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
33. Murphy L.J., Ghahary A. Uterine insulin-like growth factor-I: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocr. Rev. 11:1990;443-453.
34. Sahlin L., Norstedt G., Eriksson H. Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver. J. Steroid Biochem. Molec. Biol. 51:1994;57-66.
35. Kaghad M., Dessarps F., Jacquemin-Sablon H., Caput D., Fradelizi D., Wollman E.E. Genomic cloning of human thioredoxin-encoding gene: mapping of the transcription start point and analysis of the promoter. Gene. 140:1994;273-278.
36. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishima T., Yamasaki Y., Kajimoto Y. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:1994;16,433-16,442.
37. Paech K., Webb P., Kuiper G.G.J.M., Nilsson S., Gustafsson J-Å, Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science. 277:1997;1508-1510.